スポンサーリンク
The Japan Society for Portal Hypertension | 論文
- タイトル無し
- Long-Term Efficacy of Transvenous Obliteration of Porto-Systemic Shunt (TOPS) Therapy for Solitary Gastric Varices
- Two Cases of Gastric Varices Developing after Endoscopic Variceal Ligation for Esophageal Varices
- A clinical pathway for transjugular retrograde obliteration of gastric varices
- Strategy for Treating Recurrent Varices after the Endoscopic Injection Sclerotherapy
- Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis
- Solitary varix of the esophagus treated by endoscopic therapy : report of two cases
- A case of liver fibrosis with resected hepatocellular carcinoma accompanied with main portal venous tumor thrombus via aberrant portal branch
- A case report of the patient with extrahepatic portal obstruction whose symptomof chronic myeloproliferative disorder appeared after non-shunt operation
- A case of idiopathic portal hypertension with primary pulmonary hypertension
- Adequate Treatment of Esophageal Varices Complicated by Gastric Cancer
- Long-term follow-up for 67 months after transjugular intrahepatic portosystemic shunting in a patient with refractory ascites : Report of a case
- A case report of long term follow-up of duodenal varices associated with extrahepatic portal obstruction.
- A comparison of the recurrence rate and the survival rate between prophylactic EIS and EVL + EIS for esophageal varices in Tokai University Hospital
- Successful treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration (B-RTO) for a patient with Wilson disease
- A case of spurting bleeding from cardiac atypical varices on liver cirrhosis type C patient after treatment of F0 esophageal varices.
- EVL:#NAME?
- Evaluation of the "Waiting Method" with Endoscopic Injection Sclerotherapy for Esophageal Varice
- A case renort ofextrahepatic portal obstruction complicated with duodenal varix successfully treated withdrug therapy
- Effect of an Angiotensin II Receptor Antagonist, Candesartan Cilexetil, on Portal Blood Flow in Liver Cirrhosis